Skip to content

Clinical trials

Phase 1 Hepatoblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatoblastoma Phase: Phase 1 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20151
20171
20181
20191
20201
20212
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Active, not recruiting3
Terminated2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Emory University3
Seattle Children's Hospital3
Masonic Cancer Center, University of Minnesota2
Baylor College of Medicine1
Children's Hospital Medical Center, Cincinnati1
Memorial Sloan Kettering Cancer Center1
New York Medical College1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
St. Jude Children's Research Hospital1
Valent Technologies, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatoblastoma15
Rhabdomyosarcoma11
Wilms Tumor11
Neuroblastoma10
Rhabdoid Tumor9
Sarcoma, Ewing9
Neoplasms, Germ Cell and Embryonal8
Sarcoma8
Osteosarcoma6
Retinoblastoma6

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.